Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study of Pembrolizumab for Patients with Vulvar Squamous Cell Carcinoma
The NetherlandsStudy on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies
GermanyStudy on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma
The NetherlandsStudy on the Long-Term Safety and Effectiveness of Pegunigalsidase Alfa for Adults with Fabry Disease
BelgiumStudy Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
BelgiumStudy on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer
LithuaniaStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy on Anifrolumab and Phototherapy for Adults with Progressive Vitiligo
FranceStudy on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
AustriaStudy on the Safety and Effectiveness of Imiquimod Gel and Cream for Treating Actinic Keratosis in Adults
SpainStudy on the Effects of Sonelokimab for Patients with Moderate-to-Severe Palmoplantar Pustulosis
GermanyStudy of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris
ItalyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
